Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.69 USD | +12.91% | +11.29% | +102.82% |
May. 24 | Monopar Therapeutics Names Karthik Radhakrishnan as CFO | MT |
May. 24 | Monopar Therapeutics Inc. Announces CFO Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+102.82% | 10.67M | |
+46.16% | 54.63B | |
-6.88% | 39.92B | |
+37.07% | 38.82B | |
+13.43% | 26.86B | |
-11.17% | 26.22B | |
-21.77% | 18.78B | |
+26.06% | 12.21B | |
+0.97% | 12.16B | |
+25.64% | 11.94B |
- Stock Market
- Equities
- MNPR Stock
- News Monopar Therapeutics Inc.
- Roth MKM Adjusts Price Target on Monopar Therapeutics to $3 From $18, Maintains Buy Rating